Help IBD Patients: Donate Now
Sign up for CCFA's Free
E-mail Newsletter:
About CCFA
Living with IBD
Information Resource Center
CCFA Community
IBD Management Choices
Disease Information
How You Can Help
Research
Chapters & Events
Kids & Teens
Advocacy
Science & Professionals
Shop Gear and Books
Enter Keyword(s):
Google Custom Search
make a donation Join CCFA Corporate Partners
Crohn's & Colitis Community

Expert Q&A Library

Welcome to our Expert Q&A Library. Here you’ll find IBD questions submitted by people like you, and answers provided by our panel of IBD experts.

You can browse the Q&As by clicking on a category on the right side of this page. Or, search a specific Q&A topic by using the “Search Q&As” tool to the right.

If you can’t find an answer to your question here, use the IBD Knowledge Navigator tool. You’ll have the opportunity to submit a question to our panel of experts at the bottom of your IBD Knowledge Navigator results page.

Most Recent

A. Ileal ulceration is a finding seen on endoscopic evaluation (such as colonoscopy or enteroscopy). Stool studies, biopsies of the abnormal region, and blood testing may be needed to determine the cause. There are several potential causes which include Crohn’s and tuberculosis (TB), but also include several other diseases. These diseases include, but are not limited to infections (parasites, bacteria, viruses such as cytomegalovirus in immunocompromised individuals), diseases of immune-dysregulation (eosinophilic gastroenteritis; vasculitis such as lupus and polyarteritis nodoum; vascular ischemia, and tumors (such as lymphoma)). Following up with a GI specialist to understand which diseases have been evaluated for is reasonable. A small percentage of Crohn’s patients are also non-responsive to medical therapy and may require surgery.

A. There is no data to state whether or not anabolic steroids cause or worsen ulcerative colitis.

A. A diagnosis of IBD can be made definitively, but patients may not have all the findings at the time of presentation to make a definitive diagnosis. Findings on testing may evolve over time and may require repeat testing to make a diagnosis of IBD. The findings on endoscopic evaluation (such as colonoscopy/endoscopy) along with the findings on biopsies are the gold standard method for diagnosis. When it is difficult to know whether someone has Crohn’s disease or ulcerative colitis, there are also blood tests that can help differentiate the diseases. Clinical remission does not always equal endoscopic remission, so it may be worthwhile repeating testing if the diagnosis was not certain from the start. Additionally, having Crohn’s or ulcerative colitis for more than 8-10 years may increase the risk for colon cancer and colonoscopy (with biopsies) is the recommended screening test.

A. The specific medical treatment options for a patient depend on the type and severity of inflammatory bowel disease. For mild/moderate disease severity, 5-aminosalicylates (5-ASA) are local anti-inflammatory medications which can be given orally or by rectum. When disease is moderate to severe immunosuppressants are used. Immunosuppressants used to treat ulcerative colitis or Crohn’s disease include corticosteroids (such as prednisone), 6-mercaptopurine or azathioprine (pro-drug of 6-mercaptopurine), methotrexate, and biologics (infliximab, adalimumab, certolizumab, natalizumab). Corticosteroids are used for flare-ups of IBD and as a bridge until non-steroid immunosuppressants work. Which medical therapy is used also depends on whether one has Crohn’s disease or ulcerative colitis. The medical therapy that is right for you would need to be discussed with your doctor. Additional information about these medical therapies is available on the CCFA website.

A. The real issue is what are the ingredients of the fitness supplement? If it includes lactose or non-digestible sugars such as sorbitol or mannitol, it may make diarrhea and abdominal discomfort symptoms worse. Too much of certain vitamins and minerals may lead to toxicity, such as vitamin A and iron but this may not directly affect ulcerative colitis. If you need to obtain more specific information about a supplement than what the label provides, then you will need to contact the manufacturer of that specific product. Contact information for the manufacturer may be found directly on the label. The FDA does not collect information about all supplements since FDA approval is not needed for the supplements to be sold. By law, dietary supplements need to be safe and data is collected by the FDA on supplements with adverse events reported.

A. All the anti-TNF therapies (adalimumab, infliximab, certolizumab) used to treat inflammatory bowel disease can increase risk for sinusitis. You may need to see your primary care or an Ear/Nose/Throat specialist to discuss methods of treating and preventing sinusitis. Another option would be to treat you with a different class of immunosuppressants, such as immunomodulators if it is feasible in your case.

A. Infliximab may induce a rash (such as folliculitis and psoriasis) and there are case reports of infliximab inducing hair loss by a psoriasis like syndrome. Some patients with psoriatic like alopecia (hair loss) and rash have responded to topical medications without stopping infliximab. You should be evaluated by a dermatologist to determine the reason for the rash and hair loss in conjunction with your gastroenterologist.

A. This is not a common direct side effect of anti-TNF therapies (certolizumab, adalimumab, and infliximab). Although, you may need to be evaluated for infections that anti-TNF therapies may predispose you to, such as thrush (yeast infection of the mouth).

A. There are several non-steroid medications aside from mesalamine. Which medications to consider depend on whether you have Crohn’s or ulcerative colitis. The non-steroid medications take time to work and will usually require bridging you to these therapies with steroids. During times of flare ups, low fiber and lactose free diets are recommended to reduce symptoms. Also recommend during flares: avoidance of aspirin and ibuprofen based products and, if you have Crohn’s disease, smoking cessation.

A. The risk of anti-TNF therapies (such as infliximab, adalimumab and certolizumab), 6-mercaptopurine or its prodrug-azathioprine, and corticosteroids have been assessed for postoperative complications in several studies. The risk of postoperative complications with anti-TNF therapy is not clearly increased based on these studies. The same is true for 6-mercaptopurine/azathioprine. Whereas for corticosteroids, if at the time of surgery it is greater than 20mg a day it may increase risk for complications. It takes at least 4 half-lives for minimal drug concentrations to remain in the blood stream. Based on a half-life of 7-9 days with infliximab, infliximab exposure 4 months ago should not affect surgery. The half life of azathioprine’s active metabolite (6TGN) is between 3-13 days, so stopping azathioprine 3 months ago should not have an effect. The half of prednisone is 3-4 hours.

A. Gluten is not a known stimulant of ulcerative colitis or Crohn’s disease. Some individuals have gluten intolerance, which causes gastrointestinal symptoms such as bloating and abdominal discomfort. So if a patient also has ulcerative colitis the gluten intolerance may add to symptoms already present.

A. The difference noted by the CDC MMWR publication refers to the risk of blood clots with the use of contraceptives in inflammatory bowel disease patients. Moderate to severely active inflammatory bowel disease increases the risk for developing blood clots. Contraceptives with higher hormonal levels (in the pill, patch, or ring) also are associated with an increase risk for blood clots. In theory, combining oral contraceptives and moderate-severe inflammatory bowel disease may increase the risk even more for developing blood clots. There is no published study as of yet that answers this question. If your disease is not very active, then a pill still may be a reasonable option. You would still need to discuss with your primary care provider or gynecologist if there are other reasons specific to your medical history that would help guide which type of contraceptive to use.

Diet/Lifestyle

A. The risk of anti-TNF therapies (such as infliximab, adalimumab and certolizumab), 6-mercaptopurine or its prodrug-azathioprine, and corticosteroids have been assessed for postoperative complications in several studies. The risk of postoperative complications with anti-TNF therapy is not clearly increased based on these studies. The same is true for 6-mercaptopurine/azathioprine. Whereas for corticosteroids, if at the time of surgery it is greater than 20mg a day it may increase risk for complications. It takes at least 4 half-lives for minimal drug concentrations to remain in the blood stream. Based on a half-life of 7-9 days with infliximab, infliximab exposure 4 months ago should not affect surgery. The half life of azathioprine’s active metabolite (6TGN) is between 3-13 days, so stopping azathioprine 3 months ago should not have an effect. The half of prednisone is 3-4 hours.

A. Gluten is not a known stimulant of ulcerative colitis or Crohn’s disease. Some individuals have gluten intolerance, which causes gastrointestinal symptoms such as bloating and abdominal discomfort. So if a patient also has ulcerative colitis the gluten intolerance may add to symptoms already present.

A. The Recommended Dietary Allowance for vitamin B12 for adults ranges from 2.4 to 2.8 mcg daily. The article suggests 1000mcg a day for patients with vitamin B12 deficiency. Since your vitamin B12 levels have been normal, you should speak with your doctor about the right dose for you. Although supplementation with excess vitamin B12 is relatively safe, there are toxicities such as blood clots that have been associated with too much vitamin B12.

A. For long distance running with Crohn’s, the most important part is to be sure you are keeping up with your hydration, both before race day and on race day. Every individual’s needs are different and dependent on their fluid losses (which includes most importantly sweat and stools (diarrhea)). An average recommendation (for people without bowel disease) is to drink 3-6oz every 15-20 minutes during the run (about 1 cup of water every other mile). For a starting point, try to estimate your sweat rate (weigh before and after a good hour run and then convert this to ounces/hour of loss). You will need to be replacing those losses plus adding more for any diarrhea and more if it is hotter. In regards to carb intake (gels and chews), be sure you take something pre-race, and then at least 45 minutes into the run, to help prevent losing steam early on. You will have to adjust this to your own body and may need to take more of these then other people given your Crohn’s. Try out various formulations to see what works best for you. Make a hydration and nutrition plan for race day beforehand and talk it over with your doctor to further tailor it to the specifics of your disease.

A. First things first, in regards to poor energy, be sure to talk with your doctor to ensure that your Crohn’s disease is adequately treated. Next, nutrition during training for long distance running is important both for people with and without Crohn’s disease. You should be eating a healthy, balanced diet in addition to being sure you are staying adequately hydrated. Carbs are important in all your meals to provide the energy stores you need for running and protein is especially important post-race to help repair your body. On race days, you can try to eat something light (like a banana or a bagel or something you know you digest well) before the run. It is also important with long runs to consume snacks during the run. There are a wide variety of energy supplements (carbs) that come as gels, chews, or bars that you can take during the run. You want to be sure to consume these early on in the run, and then periodically throughout (make sure you don’t wait too long and lose steam). Many recommend these every 30-45 minutes during the run. You will have to try various products and see what works best for you. And again, being sure you are adequately hydrated is a very important part of this as well.

A. There is a rather obvious link between diet and gastrointestinal illnesses. Unfortunately, it is not a very well understood link at this point in time. What’s certain is that the “wrong” diet will not result in any prolonged negative effects. That being the case, you should feel free to experiment with low or high fiber diets, with the assistance of an expert, until you find the one that’s right for you. No matter the choice, you won’t harm your Crohn’s, IBS, or diverticulosis.

A. A diet high in protein calories is the best thing for him at this time. It would likely be advisable for him to meet with a nutritionist to get a detailed description of how to accomplish this, but all calories are good calories and high protein calories are best.

A. Probiotics have not been shown to be beneficial for collagenous colitis or celiac disease. Patients with untreated or poorly treated celiac disease can develop malaborption of vitamins and minerals like vitamin D and calcium. Therefore, screening for deficiency in vitamin D and repleting the vitamin D if the level is low is reasonable. Also, screening for bone loss related to celiac disease with a DEXA or bone density is indicated. If bone loss is present, calcium and vitamin D supplements should be given. If the celiac disease is under good control and the bone mineral density is normal, calcium and vitamin D would only be needed if you are not getting sufficient intake in the diet. A daily multivitamin is a reasonable thing for all patients to take. Cholestyramine is not a vitamin but is used as a treatment of the collagenous colitis.

A. Beano (the enzyme that helps break down the sugar found in many types of beans) literally only works on breaking down arabinose, which is the sugar in beans. If you do not eat beans, then Beano will not help you. Simethicone breaks up gas bubbles that are in the stomach, but if the gas has already reached your intestine, then simethicone will not help either. Simethicone however is certainly safe to take.

Disease Education

A. Ileal ulceration is a finding seen on endoscopic evaluation (such as colonoscopy or enteroscopy). Stool studies, biopsies of the abnormal region, and blood testing may be needed to determine the cause. There are several potential causes which include Crohn’s and tuberculosis (TB), but also include several other diseases. These diseases include, but are not limited to infections (parasites, bacteria, viruses such as cytomegalovirus in immunocompromised individuals), diseases of immune-dysregulation (eosinophilic gastroenteritis; vasculitis such as lupus and polyarteritis nodoum; vascular ischemia, and tumors (such as lymphoma)). Following up with a GI specialist to understand which diseases have been evaluated for is reasonable. A small percentage of Crohn’s patients are also non-responsive to medical therapy and may require surgery.

A. There is no data to state whether or not anabolic steroids cause or worsen ulcerative colitis.

A. A diagnosis of IBD can be made definitively, but patients may not have all the findings at the time of presentation to make a definitive diagnosis. Findings on testing may evolve over time and may require repeat testing to make a diagnosis of IBD. The findings on endoscopic evaluation (such as colonoscopy/endoscopy) along with the findings on biopsies are the gold standard method for diagnosis. When it is difficult to know whether someone has Crohn’s disease or ulcerative colitis, there are also blood tests that can help differentiate the diseases. Clinical remission does not always equal endoscopic remission, so it may be worthwhile repeating testing if the diagnosis was not certain from the start. Additionally, having Crohn’s or ulcerative colitis for more than 8-10 years may increase the risk for colon cancer and colonoscopy (with biopsies) is the recommended screening test.

A. While it is possible to have both IBD and IBS, the two disorders can be distinguished by symptoms and by laboratory, x-rays, or endoscopic data. Patients with IBS can have a wide array of symptoms but typically have chronic abdominal pain and altered bowel habits. Patients with IBD who are having a flare often present with increased frequency of bowel movements, rectal bleeding, and abdominal pain. During more severe flares, IBD patients can have fevers, weight loss, laboratory abnormalities, or other manifestations such as inflamed joints or rashes. A colonoscopy, appropriate x-rays, and/or laboratory tests can be done to help determine whether symptoms are from IBD or IBS.

A. It is certainly possible that the bright red blood is due to hemorrhoids, a tear (fissure), or from active ulcerative colitis. You should encourage your daughter to follow up with her gastroenterologist to help determine the source of the blood so that she can receive the appropriate treatment.

A. Anemia is a very common problem in IBD. Although many patients report that they do not experience any symptoms from the anemia, many studies have shown that anemia has a significant negative impact on quality of life. The most common cause of anemia in IBD is iron deficiency (related to gastro-intestinal blood loss). Anemia of chronic disease often occurs at the same time due to immune mediated impaired formation of red blood cells and inappropriate iron metabolism. Both oral and intravenous iron therapy have been shown to be effective in treating iron deficiency, and consequently improve quality of life. Another cause for anemia is from a low B12 level. Low B12 levels can develop in patients with active Crohn’s disease or in Crohn’s patients after removal of the terminal ileum (last part of the small intestines).

A. Crohn’s disease (CD) is not a fatal disease. Many studies suggest that CD is associated with only a small decrease in overall life expectancy. The typical course for patients with CD includes intermittent worsening of symptoms follow by periods of remission. Patients who have active disease within the past year have a 70% chance of remaining active in the forthcoming year and a 50% chance of being in remission within the following 3 years. Patients can either have mild, moderate or more aggressive disease, and many patients with CD ultimately require surgical intervention. Patients with the more aggressive form of the disease can have earlier return of their Crohn’s disease after surgery and may need more surgery.

A. Ulcerative colitis (UC) can be associated with a variety of skin problems that cause inflammation. Occasionally, these skin problems can be a sign of progressive disease even in the absence of gastrointestinal symptoms. However, cuts behind your ear lobe seem unlikely to be associated with your UC. Given that these cuts have been occurring for a few months, you should follow up with your physician, who might then recommend you to see a skin specialist (dermatologist).

A. There are a number of things that could be going on to cause your symptoms and you should discuss this with your doctor. Sometimes IBD can be associated with arthritis and this would be at the top of my concerns. If that is the case your doctor may want to send you to see an arthritis specialist and/or choose medications for your IBD that will also help treat arthritis. Arthritis associated with IBD (called spondyloarthropathy) can affect various joints, including the back and pelvis joints and/or the large or small joints of your extremities.

A. All antibiotics can upset the gastrointestinal system, in part by changing the gut’s flora, the organisms that reside in the gut. For this reason, antibiotics should be used judiciously, such as when a treating physician is reasonably certain that there is a bacterial infection, as opposed to a viral infection.

Special Poputations

A. The difference noted by the CDC MMWR publication refers to the risk of blood clots with the use of contraceptives in inflammatory bowel disease patients. Moderate to severely active inflammatory bowel disease increases the risk for developing blood clots. Contraceptives with higher hormonal levels (in the pill, patch, or ring) also are associated with an increase risk for blood clots. In theory, combining oral contraceptives and moderate-severe inflammatory bowel disease may increase the risk even more for developing blood clots. There is no published study as of yet that answers this question. If your disease is not very active, then a pill still may be a reasonable option. You would still need to discuss with your primary care provider or gynecologist if there are other reasons specific to your medical history that would help guide which type of contraceptive to use.

A. A decreased ability to absorb what you eat in the setting of active small intestinal Crohn’s disease might lead to a decrease in the effectiveness of contraceptive pills taken by mouth. Oral contraceptives are mainly absorbed in the small bowel and contraceptive efficacy depends on its absorptive capacity. However, limited evidence suggests that there are no differences in the absorption of higher-dose oral contraceptives between women with mild UC and small ileal resections and health women.

A. Medical treatments with potential efficacy for treating perianal disease include antibiotics, azathioprine and 6MP, biologics like infliximab and adalimumab, and cyclosporine and tacrolimus. Depending on the specifics of your disease, surgical treatments are a consideration as well, and you should discuss this with your doctor.

A. There is no data that I am aware of that has linked the mechanisms (or “chemistry”) of inflammatory bowel disease to causing depression. However, depression is very commonly seen in patients with IBD given the lifelong illness it causes. CCFA has many resources available regarding coping and emotional factors. Be sure to contact our Information Resource Center (888.694.8872) to learn more and check out our educational brochures and fact sheets at http://www.ccfa.org/info/brochures.

A. There have been no controlled studies looking at the safety of taking human growth hormone while also receiving a biologic.

A. In general, mesalamines are considered safe during pregnancy. With that said, olsalazine and asacol contain dibutyl pthalatae (DBP) in the coating. Neither of these medications has been associated with birth defects, but DBP has been associated with congenital anomalies in animals. With that said, it is even more important to consider the effects of a flare if these medications are stopped. Active disease during pregnancy can increase the risks of pre-term delivery and low birth weight of the infant. It may also impair the ability of the mother to care for the infant once it is born. Plus even stronger medicines may be required to get mom back under control if she flares.

A. The SSD application should allow for including information about functional limitations related to both your back and your gut. Supporting documentation from your doctors should help. CCFA has sample appeal letters that you or your health care provider can use. Visit the Community Resource Center (http://www.ccfacommunity.org/ResourceCenter.aspx) for more information.

A. In general, most gastroenterology society guidelines do not recommend screening or surveillance colonoscopies in patients of advanced age, such as 85 and older. The decision about continuing screening or surveillance colonoscopies in your case should be discussed with your treating physician. I often consider the following factors when deciding whether or not to pursue further colonoscopies for screening or surveillance in older patients. First, if a problem is detected, is the patient well enough to undergo surgery? Second, would the patient seek treatment if a problem were discovered (for example, would a patient agree to a removal of the colon if cancer were found)? Lastly, are other health problems present which limit the patients 5 year survival? In general, the more other severe health problems that are present make ongoing colonoscopies less beneficial.

Treatment

A. The specific medical treatment options for a patient depend on the type and severity of inflammatory bowel disease. For mild/moderate disease severity, 5-aminosalicylates (5-ASA) are local anti-inflammatory medications which can be given orally or by rectum. When disease is moderate to severe immunosuppressants are used. Immunosuppressants used to treat ulcerative colitis or Crohn’s disease include corticosteroids (such as prednisone), 6-mercaptopurine or azathioprine (pro-drug of 6-mercaptopurine), methotrexate, and biologics (infliximab, adalimumab, certolizumab, natalizumab). Corticosteroids are used for flare-ups of IBD and as a bridge until non-steroid immunosuppressants work. Which medical therapy is used also depends on whether one has Crohn’s disease or ulcerative colitis. The medical therapy that is right for you would need to be discussed with your doctor. Additional information about these medical therapies is available on the CCFA website.

A. The real issue is what are the ingredients of the fitness supplement? If it includes lactose or non-digestible sugars such as sorbitol or mannitol, it may make diarrhea and abdominal discomfort symptoms worse. Too much of certain vitamins and minerals may lead to toxicity, such as vitamin A and iron but this may not directly affect ulcerative colitis. If you need to obtain more specific information about a supplement than what the label provides, then you will need to contact the manufacturer of that specific product. Contact information for the manufacturer may be found directly on the label. The FDA does not collect information about all supplements since FDA approval is not needed for the supplements to be sold. By law, dietary supplements need to be safe and data is collected by the FDA on supplements with adverse events reported.

A. All the anti-TNF therapies (adalimumab, infliximab, certolizumab) used to treat inflammatory bowel disease can increase risk for sinusitis. You may need to see your primary care or an Ear/Nose/Throat specialist to discuss methods of treating and preventing sinusitis. Another option would be to treat you with a different class of immunosuppressants, such as immunomodulators if it is feasible in your case.

A. Infliximab may induce a rash (such as folliculitis and psoriasis) and there are case reports of infliximab inducing hair loss by a psoriasis like syndrome. Some patients with psoriatic like alopecia (hair loss) and rash have responded to topical medications without stopping infliximab. You should be evaluated by a dermatologist to determine the reason for the rash and hair loss in conjunction with your gastroenterologist.

A. This is not a common direct side effect of anti-TNF therapies (certolizumab, adalimumab, and infliximab). Although, you may need to be evaluated for infections that anti-TNF therapies may predispose you to, such as thrush (yeast infection of the mouth).

A. There are several non-steroid medications aside from mesalamine. Which medications to consider depend on whether you have Crohn’s or ulcerative colitis. The non-steroid medications take time to work and will usually require bridging you to these therapies with steroids. During times of flare ups, low fiber and lactose free diets are recommended to reduce symptoms. Also recommend during flares: avoidance of aspirin and ibuprofen based products and, if you have Crohn’s disease, smoking cessation.

A. Several studies have shown that budesonide is effective for induction of remission in mild to moderate ileal and ileocecal Crohn’s disease. In these studies, patients were on budesonide 9mg/day for 8 to 12 weeks. However, patients have reported improvement in symptoms as early as a few days from starting therapy. There was no improved benefit seen on higher dose of budesonide.

A. Infliximab has been shown to cause severe shakes (rigors) during an infusion. Otherwise, the infliximab suppresses your immune system and as a result makes you more likely to get an infection which can cause you to have the shakes and chills. Taking a higher dose of prednisone at times when you have the chills/shakes can be dangerous as the prednisone can worsen the infection. You should see your gastroenterologist to discuss these symptoms to determine if there are other causes for your chills and rigors.

A. Mercaptopurine has been shown to be effective in reducing the risk of Crohn’s disease recurrence. Many patients can remain on mercaptopurine indefinitely if needed to control their IBD. Others can be tapered off after several years. Do not stop your mercaptopurine or any of your IBD medications without first speaking to your gastroenterologist.

A. There is no good data to date to show that aloe benefits colitis. Moreover, there are many forms of aloe and some can even be harmful to the colon. Furthermore, it is difficult to know which of these forms you are getting when you buy it. Studies are ongoing in animals, but at this point it is not a recommended treatment for colitis.

Search Q&As

Search by Topic:

The information contained within the Expert Q&A Library is for educational purposes only and is not meant to diagnose medical conditions, offer treatment recommendations or take the place of talking with a doctor. Any information found on this site should be discussed with a health care professional.


  CrohnsOnline.com
* Any information on the Crohn's & Colitis Community site should not replace your physician's advice. Always check with your personal physician before taking any action regarding your health.
© 2010 CCFA | All medical information on this web site has been reviewed by members of CCFA's National Scientific Advisory Committee
Privacy Policy | Contact Us